Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
CCAAT/Enhancer-binding Protein β Deletion Reduces Adiposity, Hepatic Steatosis, and Diabetes in Lepr Mice
2007
Health care-associated infections – an overview
2018 Standout
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
2007
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
2010
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Alcohol consumption appears to protect against non-alcoholic fatty liver disease
2010
Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the Liver
2007
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity
2017
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
2008
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
2010 Standout
Roles of alcohol consumption in fatty liver: A longitudinal study
2014
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Association between nonalcoholic fatty liver disease and coronary artery disease
2007
Amino acids: metabolism, functions, and nutrition
2009 Standout
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
2008 Standout
Prevalence of fatty liver disease and its risk factors in the population of South China
2007
Impact of Fatty Liver Disease on Health Care Utilization and Costs in a General Population: A 5-Year Observation
2007
Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment
2008
Disruption of BCATm in Mice Leads to Increased Energy Expenditure Associated with the Activation of a Futile Protein Turnover Cycle
2007
Transcriptional Regulation of Metabolism
2006
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
2009 Standout
Non-Alcoholic Fatty Liver Disease in Older People
2009
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Triglyceride Levels and Not Adipokine Concentrations Are Closely Related to Severity of Nonalcoholic Fatty Liver Disease in an Obesity Surgery Cohort
2009
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Independent effects of physical activity in patients with nonalcoholic fatty liver disease #
2009
Psoriasis
2015 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease
2016
Lack of Exercise Is a Major Cause of Chronic Diseases
2012 Standout
Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study
2013
Nonalcoholic Fatty Liver Disease: Cytokine-Adipokine Interplay and Regulation of Insulin Resistance
2006
Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: Therapeutic implications for hepatitis C
2008
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels # †
2009
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
2008
Familial Aggregation of Insulin Resistance in First-Degree Relatives of Patients With Nonalcoholic Fatty Liver Disease
2006
Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C
2007
Identification and Characterization of Metabolically Benign Obesity in Humans
2008
NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
2019 Standout
Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia, and hepatic steatosis in db/db mice
2010
Global burden of liver disease: 2023 update
2023 Standout
Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle Insulin Resistance
2008 Standout
Transient prenatal androgen exposure produces metabolic syndrome in adult female rats
2008
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
2006 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Does Hepatic Steatosis Affect Drug Metabolizing Enzymes in the Liver?
2011
Insulin Resistance and Dysregulation of Tryptophan–Kynurenine and Kynurenine–Nicotinamide Adenine Dinucleotide Metabolic Pathways
2013
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
IDENTIFYING NON-ALCOHOLIC FATTY LIVER DISEASE AMONG ASYMPTOMATIC OVERWEIGHT AND OBESE INDIVIDUALS BY CLINICAL AND BIOCHEMICAL CHARACTERISTICS
2009
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
2006
Determinants of Disuse-Induced Skeletal Muscle Atrophy: Exercise and Nutrition Countermeasures to Prevent Protein Loss
2006
SREBP-1c Transcription Factor and Lipid Homeostasis: Clinical Perspective
2007
Extrahepatic complications of nonalcoholic fatty liver disease
2013
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
2018 Standout
Energy Metabolism in the Liver
2014 Standout
Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease
2011
Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population
2013
Clinical trial: insulin‐sensitizing agents may reduce consequences of insulin resistance in individuals with non‐alcoholic steatohepatitis
2008
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
NAFLD: A multisystem disease
2015 Standout
A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
2013
Nutrition Support and Infections Associated With Hepatic Resection and Liver Transplantation in Patients With Chronic Liver Disease
2012
A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patients
2006
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question
2007
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Postprandial Lipemia Associates with Liver Fat Content
2007
Nosocomial infections in the medical ICU: a retrospective study highlighting their prevalence, microbiological profile and impact on ICU stay and mortality.
2014
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
2007
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose
2013 Standout
Role of Nutrition in the Management of Hepatic Encephalopathy in End-Stage Liver Failure
2010
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism
2010
The Metabolic Syndrome
2008 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Works of F. Agostini being referenced
Update on nutritional supplementation with branched-chain amino acids
2004
Review article: the treatment of fatty liver disease associated with the metabolic syndrome
2005
Nonalcoholic fatty liver disease and the metabolic syndrome
2005
Epidemiology of nosocomial infection in 125 Italian intensive care units.
2010
Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control
2012